Table 2 Surgery, perioperative, and postoperative outcomes
Variable | n (%)/[range] | P value |
|---|---|---|
Surgery, (VATS) | Â | 0.603 |
 Lobectomy | 14 (73.7) | |
   n= RUL/RML/RLL/LUL/LLL | 3/1/5/2/3 | |
 Sublobar resection | 5 (26.3) | |
  n=Trisegmentectomy/lingulectomy/subsegmentectomy/Wedge resection | 2/1/1/1 | |
Number of lymphadenectomy, median | 20 [5-38] | Â |
Complete resection | Â | 1.000 |
 R0 | 17 (89.5) | |
 R2 | 2 (10.5) | |
Duration of surgery, median minutes | 180 [60-380] | 0.020 |
Blood loss, median ml | 40 [10-550] | 0.049 |
Postoperative complications | Â | 0.614 |
 Bleeding | 1 (5.3) | |
 Thoracic empyema | 1 (5.3) | |
 Nil | 17 (89.5) | |
30-day postoperative mortality | 0 (0) | Â |
Median time to relapse, months | 13 [6-41] | Â |
Relapse | Â | <0.001 |
 Alive without relapse | 10 (52.6) | |
 Alive with relapse | 2 (10.5) | |
 Died with relapse | 7 (36.8) | |
T790M status | Â | Â |
 Positive | 1 (5.3) | |
 Negative | 1 (5.3) | |
 Unknown/not done | 17 (89.4) | |
Recurrence pattern | Â | <0.001 |
 Intrathoracic recurrence/metastases | 2 (10.5) | |
 Distant metastases | 3 (15.8) | |
 Intrathoracic and distant metastases | 4 (21.1) | |
 Nil | 10 (52.6) | |
Postoperative adjuvant therapy | Â | 0.129 |
 TKI | 13 (68.4) | |
 Non-TKI | 6 (31.6) |